JC

Jon E. Chatterton

AR Alcon Research: 22 patents #4 of 267Top 2%
AP Arrowhead Pharmaceuticals: 12 patents #10 of 121Top 9%
AR Arrowhead Research: 9 patents #1 of 49Top 3%
PB Precision Biosciences: 5 patents #9 of 22Top 45%
YU Yale University: 2 patents #418 of 1,662Top 30%
AL Alcon: 2 patents #370 of 866Top 45%
TF Thermo Fisher: 2 patents #942 of 2,015Top 50%
NA Novartis Ag: 2 patents #1,923 of 5,128Top 40%
SI Sanford-Burnham Medical Research Institute: 2 patents #24 of 162Top 15%
BH Brigham and Women's Hospital: 2 patents #490 of 1,764Top 30%
📍 Aliso Viejo, CA: #12 of 729 inventorsTop 2%
🗺 California: #6,949 of 386,348 inventorsTop 2%
Overall (All Time): #47,475 of 4,157,543Top 2%
54
Patents All Time

Issued Patents All Time

Showing 26–50 of 54 patents

Patent #TitleCo-InventorsDate
9114152 Transferrin/transferrin receptor-mediated siRNA delivery Abbot F. Clark 2015-08-25
9040494 RNAi-mediated inhibition of frizzled related protein-1 for treatment of glaucoma Abbot F. Clark, Wan-Heng Wang, Loretta McNatt 2015-05-26
8940887 RNAi-mediated inhibition of HIF1A for treatment of ocular angiogenesis David P. Bingaman 2015-01-27
8937051 Low density lipoprotein receptor-mediated siRNA delivery 2015-01-20
8865670 RNAi-related inhibition of TNFα signaling pathway for treatment of glaucoma Abbot F. Clark, David P. Bingaman, Martin B. Wax, Adrian M. Timmers 2014-10-21
8865671 RNAi-mediated inhibition of spleen tyrosine kinase-related inflammatory conditions John M. Yanni, Daniel A. Gamache, Steven T. Miller 2014-10-21
8754202 RNAi-related inhibition of TNFα signaling pathway for treatment of ocular angiogenesis Abbot F. Clark, David P. Bingaman, Martin B. Wax, Adrian M. Timmers 2014-06-17
8673873 RNAi-mediated inhibition of phosphodiesterase type 4 for treatment of cAMP-related ocular disorders John M. Yanni, Daniel A. Gamache, Steven T. Miller 2014-03-18
8664375 Interfering RNA delivery system and uses thereof 2014-03-04
8618278 RNAi-mediated inhibition of histamine receptor H1-related conditions John M. Yanni, Daniel A. Gamache, Steven T. Miller 2013-12-31
8569258 Low density lipoprotein receptor-mediated siRNA delivery 2013-10-29
8546349 siRNA targeting VEGFA and methods for treatment in vivo Anja Smith, Angela Reynolds, Xinyu Zhang 2013-10-01
8541389 RNAi-mediated inhibition of tumor necrosis factor α-related conditions John M. Yanni, Diane Michelle Senchyna, Daniel A. Gamache, Steven T. Miller 2013-09-24
8471000 RNAi-mediated inhibition of HIF1A for treatment of ocular angiogenesis David P. Bingaman 2013-06-25
8399653 Transferrin/transferrin receptor-mediated siRNA delivery Abbot F. Clark 2013-03-19
8268798 Low density lipoprotein receptor-mediated siRNA delivery 2012-09-18
8222227 RNAi-mediated inhibition of histamine receptor H1-related conditions John M. Yanni, Daniel A. Gamache, Steven T. Miller 2012-07-17
8193315 Excitatory glycine receptors and methods Stuart A. Lipton, Dongxian Zhang, Kevin Sevarino, Marc Awobuluyi 2012-06-05
8173617 RNAi-mediated inhibition of frizzled related protein-1 for treatment of glaucoma Abbot F. Clark, Wan-Heng Wang, Loretta McNatt 2012-05-08
8168609 RNAi-mediated inhibition of Rho kinase for treatment of ocular disorders Abbot F. Clark 2012-05-01
8048863 RNAi-mediated inhibition of spleen tyrosine kinase-related inflammatory conditions John M. Yanni, Daniel A. Gamache, Steven T. Miller 2011-11-01
8017592 RNAi-mediated inhibition of histamine receptor H1-related conditions John M. Yanni, Daniel A. Gamache, Steven T. Miller 2011-09-13
7981870 RNAi-mediated inhibition of H1F1A for treatment of ocular angiogenesis David P. Bingaman 2011-07-19
7973019 Transferrin/transferrin receptor-mediated siRNA delivery Abbot F. Clark 2011-07-05
7947660 RNAi-mediated inhibition of frizzled related protein-1 for treatment of glaucoma Abbot F. Clark, Wan-Heng Wang, Loretta McNatt 2011-05-24